Our data showed an increased tumor burden in the PDO-c-Jun-OE group compared to the PDO-vector group and that overexpression of c-Jun prevented the gemcitabine-induced decrease in the tumor burden (Fig. 6F-H). Here, JUN is linked to neoplasm.